Literature DB >> 17805247

A case of levodopa-responsive camptocormia associated with advanced Parkinson's disease.

Bryan Ho1, Rajan Prakash, John C Morgan, Kapil D Sethi.   

Abstract

BACKGROUND: A 48-year-old man with a 9-year history of Parkinson's disease who had previously shown a good response to levodopa presented for evaluation of increasingly disabling motor fluctuations and marked camptocormia. INVESTIGATIONS: Video-recorded neurological examinations when in 'off' and 'on' states, brain MRI scan. DIAGNOSIS: Advanced Parkinson's disease complicated by levodopa-responsive camptocormia. MANAGEMENT: Adjustment of dopaminergic therapy (carbidopa-levodopa and entacapone) to minimize motor fluctuations and camptocormia.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17805247     DOI: 10.1038/ncpneuro0584

Source DB:  PubMed          Journal:  Nat Clin Pract Neurol        ISSN: 1745-834X


  5 in total

Review 1.  Camptocormia in Parkinson's disease: definition, epidemiology, pathogenesis and treatment modalities.

Authors:  Prachaya Srivanitchapoom; Mark Hallett
Journal:  J Neurol Neurosurg Psychiatry       Date:  2015-04-20       Impact factor: 10.154

Review 2.  Recent advancements in lateral trunk flexion in Parkinson disease.

Authors:  Hiroshi Kataoka; Kazuma Sugie
Journal:  Neurol Clin Pract       Date:  2019-02

3.  Effect of neurostimulation on camptocormia in Parkinson's disease depends on symptom duration.

Authors:  Walter J Schulz-Schaeffer; Nils G Margraf; Sari Munser; Arne Wrede; Carsten Buhmann; Günther Deuschl; Christian Oehlwein
Journal:  Mov Disord       Date:  2015-02-12       Impact factor: 10.338

4.  Effectiveness of spinal cord stimulation for painful camptocormia with Pisa syndrome in Parkinson's disease: a case report.

Authors:  Hisanao Akiyama; Saki Nukui; Masashi Akamatu; Yasuhiro Hasegawa; Osamu Nishikido; Soichiro Inoue
Journal:  BMC Neurol       Date:  2017-08-03       Impact factor: 2.474

Review 5.  Pathophysiological Concepts and Treatment of Camptocormia.

Authors:  N G Margraf; A Wrede; G Deuschl; W J Schulz-Schaeffer
Journal:  J Parkinsons Dis       Date:  2016-06-16       Impact factor: 5.568

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.